CH

Chemometec A/SDUS Chemometec Stock Report

Last reporting period 30 Jun, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

1.07

Small

Exchange

XDUS - Boerse Duesseldorf

CHY.DU Stock Analysis

CH

Attractive

Based on Eyestock quantitative analysis, CHY.DU`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

123/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

32.0 %

Undervalued

Market cap $B

1.07

Dividend yield

2.76 %

Shares outstanding

17.402 B

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.

View Section: Eyestock Rating